Cite
HARVARD Citation
Migliorini, D. et al. (2019). Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Neuro-oncology. 21 (7), pp. 923-933. [Online].